Highlights

• NIBE shares gained 13 percent after defence trial update from the company.
• Vayu Astra-1 loitering munition completed 100-kilometre technical trial for Indian Army requirements.
• High-altitude endurance and anti-armor strike capabilities featured in the latest operational demonstration.

Shares of NIBE Limited (NSE:NIBE) remained among the top market gainers on May 22, 2026, after the company announced successful technical trials of its Vayu Astra-1 loitering munition system.

The stock traded around Rs 1,456.90 during the session, up 12.90 percent from the previous close of Rs 1,290.40 on the National Stock Exchange of India Limited. The stock also touched an intraday high of Rs 1,470.

Source: TradingView

Vayu Astra-1 Completes Technical Trials

According to the company, the Vayu Astra-1 loitering munition completed technical trials at Pokhran in Rajasthan and Joshimath-Malari in Uttarakhand.

NIBE stated that the anti-personnel strike trial involved a 10-kilogram warhead striking a target located 100 kilometres away in a single attempt. The company added that the system demonstrated abort, attack and re-attack capabilities with a circular error probability, or CEP, below one metre.

The company also conducted an anti-armor night strike using an infrared camera system. According to the release, the system achieved target impact within a two-metre CEP and demonstrated handover of operational control from the ground control station to a forward control station located 70 kilometres away.

High-Altitude Endurance Operations Highlighted

NIBE stated that the Vayu Astra-1 loitering munition achieved endurance flight exceeding 90 minutes during high-altitude operations conducted at more than 14,000 feet in Uttarakhand. The company said the loitering munition was safely recovered after mission completion for future operational use.

NIBE described itself as a defence technology company engaged in development, manufacturing and integration of defence systems, with focus areas including indigenous defence capability and export opportunities.

Source: Analysis by Kalkine 

Stock Performance and Trading Activity

Exchange data showed that NIBE shares delivered gains of 44.79 percent over one week and 34.96 percent over one month. However, the stock remained marginally negative on a one-year basis.

The stock also carried exchange indicators showing close-to-close price movement greater than 25 percent during the previous five trading sessions, reflecting elevated volatility.

Key Risks Investors Should Track

• Defence order execution timelines may affect revenue visibility and cash flows.
• High stock volatility may lead to sharp short-term price fluctuations.
• Dependence on government procurement can impact business momentum.
• Defence technology projects may face testing, approval or deployment delays.

Summary

NIBE (NSE:NIBE) share price surged after the company announced successful technical trials of its Vayu Astra-1 loitering munition system. The trials included anti-personnel strikes, anti-armor operations and high-altitude endurance demonstrations linked to Indian Army requirements. Investors may continue tracking defence procurement developments, execution timelines, order inflows and stock volatility in the coming quarters.

FAQs

Q: Why did NIBE shares rise sharply on May 22, 2026?
A: NIBE shares gained after the company announced successful technical trials of its Vayu Astra-1 loitering munition system.

Q: What capabilities were demonstrated during the Vayu Astra-1 trials?
A: The system demonstrated anti-personnel strikes, anti-armor capability and high-altitude endurance operations during technical trials.

Q: What are the key risks associated with NIBE stock?
A: Investors may monitor defence order dependency, project execution risks and elevated stock price volatility closely.